Searchable abstracts of presentations at key conferences in endocrinology

ea0070ep51 | Adrenal and Cardiovascular Endocrinology | ECE2020

ACTH-independent subclinical Cushing’s syndrome secondary to primary bilateral macronodular adrenal hyperplasia

Lavinia Popa Maria , Simona Andreea Găloiu

Introduction: Primary bilateral macronodular adrenal hyperplasia (PBMAH) is an uncommon cause (<1%) of endogenous Cushing’s syndrome (CS). Recently, due to increased number of incidental imaging findings of PBMAH, the clinical expression of the disease has changed in favor of oligosymptomatic or subclinical cases, compared to those with clinically manifest CS, or rarely with secretion of mineralocorticoids, or sex steroids.Case report: A 51-yea...

ea0073aep855 | Late Breaking | ECE2021

An unusual presentation of a metastatic typical bronchial carcinoid

Lavinia Popa Maria , Găloiu Simona Andreea , Adriana Iordan Ingrid , Poiana Catalina

IntroductionLung Neuroendocrine tumors (NETs) range in aggressiveness from low-grade typical carcinoid (TC) and intermediate-grade atypical carcinoid (AC) to the high-grade large cell neuroendocrine carcinoma (LCNEC) and small cell lung carcinoma (SCLC). TC have excellent prognosis post-surgery and European Neuroendocrine Tumor Society (ENETS) recommands no adjuvant therapy for these well diferentiated tumors.Case report<p clas...

ea0099ep1003 | Calcium and Bone | ECE2024

Case report - congenital ichthyosis and hypoparathyroidism with hypocalcemic seizures in a teenager

Mirica Alexandra , Lavinia Popa Maria , Diaconeasa Adriana , Monica Preda Diana , Loreta Paun Diana

Introduction: Congenital ichthyoses are a group of inherited keratinization disorders that pose a challenge in terms of diagnosis, treatment, and clinical associations with other pathologies. The association with vitamin D deficiency and possible bone changes is cited, but the exact mechanism of occurrence of endocrine pathologies is not described.Case report: We report the case of a 16-year-old teenage boy known to have congenital ichthyosis, having bee...

ea0099ep87 | Pituitary and Neuroendocrinology | ECE2024

Growth without growth hormone: an unusual presentation of a pituitary stalk interruption syndrome

Lavinia Popa Maria , Diana Preda , Mirica Alexandra , Lidia Radomir , Mihaly Enyedi , Gherlan Iuliana

Introduction: Pituitary Stalk Interruption Syndrome (PSIS) is a congenital developmental anomaly affecting the pituitary gland. Characterized by a triad of features including a thin or absent pituitary stalk, adenohypophysis hypoplasia, and ectopic neurohypophysis on MRI, PSIS can lead to isolated or combined pituitary hormone deficiency. Symptoms may manifest at various life stages, with 70% of cases identified in childhood due to growth retardation. Notably, some patients ex...

ea0090ep1132 | Late Breaking | ECE2023

Rare phenotype association between pulmonary NET and prolonged hyperkalemia after an unilateral adrenalectomy for primary hyperaldosteronism

Tănasie Denisa-Isabella , Simona Andreea Găloiu , Lavinia Popa Maria , Iordan Ingrid , Constantin Teodor , Iorgulescu Radu , Poiana Catalina

Introduction: We describe the case of a 68-year-old patient, having two MEN1-associated tumors that are not part of the classical triad, with a penetrance of only 40%, and 2%, according to the medical literature. Furthermore, she developed a persistent hyperkalemia after the unilateral adrenalectomy, which is rare and often missed.Case report: In 2011, following a non-specific symptomatology (dry cough, fatigue), a bilobectomy was performed (medium and r...

ea0070aep663 | Pituitary and Neuroendocrinology | ECE2020

Efficacy of monotherapy versus combined GH receptor antagonist therapy in patients with somatostatin receptor analogues resistant acromegaly

Simona Andreea Găloiu , Margarit Emma , Lavinia Popa Maria , Baciu Ionela , Niculescu Dan , Trifanescu Raluca , Serban Radian , Dumitrașcu Anda , Caragheorgheopol Andra , Poiana Catalina

Background and Aims: GH receptor antagonist (Pegvisomant –PEG) has been shown to obtain IGF1 normalization in 60–90% of patients with acromegaly in clinical trials. The aim of the study is to evaluate real life response and side effects of PEG treatment in monotherapy versus combined with somatostatin analogues and/or cabergoline in patients with somatostatin analogues resistant acromegaly.Methods: We included 40 patients (22F/18 M) cons...

ea0073aep659 | Thyroid | ECE2021

Outcome of Long Term Antithyroid Therapy in Patients with Graves’ Hyperthyroidism

Găloiu Simona Andreea , Lavinia Popa Maria , Margarit Emma , Baciu Ionela , Alexandru Niculescu Dan , Capatina Cristina , Trifanescu Raluca , Radian Serban , Baculescu Nicoleta , Poiana Catalina

Graves’ disease is an autoimmune thyroid disease which, untreated, carries a significant morbidity risk. Treatment options for Graves’s disease have changed over the decades.AimsTo evaluate the outcome and risk factors for relapses of patients with Graves’s disease treated with antithyroid drugs for at least 2 years.MethodsA retrospective, analytic study on 360 consecutiv...